Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 3:23 PM UTC
| NCT Number | NCT03945162 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 125 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Theralase® Technologies Inc. |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of March 2, 2026: Clinical trial NCT03945162 is currently recruiting participants. This clinical trial study for bladder cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Theralase® Technologies Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03945162 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03945162 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.